Chemoinformaics analysis of (7S)-7-METHYL-6,7-DIHYDRO-5H-CYCLOPENTA[C]PYRIDINE-4-CARBOXYLIC ACID
| Molecular Weight | 177.203 | nRot | 1 |
| Heavy Atom Molecular Weight | 166.115 | nRig | 11 |
| Exact Molecular Weight | 177.079 | nRing | 2 |
| Solubility: LogS | -2.497 | nHRing | 1 |
| Solubility: LogP | 1.705 | No. of Aliphatic Rings | 1 |
| Acid Count | 1 | No. of Aromatic Rings | 1 |
| Base Count | 0 | No. of Aliphatic Carbocycles Rings | 1 |
| Atoms Count | 24 | No. of Aliphatic Hetero Cycles | 0 |
| No. of Heavy Atom | 13 | No. of Aromatic Carbocycles | 0 |
| nHetero | 3 | No. of Aromatic Hetero Cycles | 1 |
| nBridge Head | 0 | No. Saturated Carbocycles | 0 |
| No. of Hydrogen atom | 11 | No. of Saturated Hetero Cycles | 0 |
| No. of Carbon atom | 10 | No. of Saturated Rings | 0 |
| No. of Nitrogen atom | 1 | No. of Arom Atom | 6 |
| No. of Oxygen atom | 2 | No. of Arom Bond | 6 |
| nHA | 2 | APOL | 26.7387 |
| nHD | 1 | BPOL | 13.0433 |
| QED | 0.711 |
| Synth | 3.116 |
| Natural Product Likeliness | 0.885 |
| NR-PPAR-gamma | 0.273 |
| Lipinski | Accepted |
| Pfizer | Accepted |
| GSK | Accepted |
| Golden Triangle | Rejected |
| Pgp-inh | 0.001 |
| Pgp-sub | 0.007 |
| HIA | 0.006 |
| CACO-2 | -4.992 |
| MDCK | 0.00000789 |
| BBB | 0.721 |
| PPB | 0.607227 |
| VDSS | 0.757 |
| FU | 0.328875 |
| CYP1A2-inh | 0.051 |
| CYP1A2-sub | 0.817 |
| CYP2c19-inh | 0.046 |
| CYP2c19-sub | 0.07 |
| CYP2c9-inh | 0.061 |
| CYP2c9-sub | 0.284 |
| CYP2d6-inh | 0.01 |
| CYP2d6-sub | 0.13 |
| CYP3a4-inh | 0.111 |
| CYP3a4-sub | 0.143 |
| CL | 2.136 |
| T12 | 0.78 |
| hERG | 0.06 |
| Ames | 0.008 |
| ROA | 0.776 |
| SkinSen | 0.579 |
| Carcinogencity | 0.21 |
| EI | 0.189 |
| Respiratory | 0.401 |
| NR-Aromatase | 0.015 |
| Antiviral | No |
| Prediction | 0.866057 |